A. Mostafa

发表

Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis

Lourdes Peña-Castillo, P. Rahman, M. Hayley, 2015, Annals of the rheumatic diseases.

Immunotherapy for Lung Cancer: Has it Finally Arrived?

D. Morris, A. Mostafa, 2014, Front. Oncol..

Novel contribution in online sample cleanup for quantitative determination of Levetiracetam in human plasma by LC-Tandem mass spectrometry

A. Mostafa, 2016 .

Interleukin-4 (IL-4) and Interleukin-4 Receptor Alpha Chain (IL-4Rα) Gene Polymorphisms in Egyptian Rheumatic Arthritis Patients

FatenA. Mohamed, A. Mostafa, Eman F. Bassiony, 2015 .

The identification of a novel HLA‐B allele, HLA‐B*27:05:38

N. Berka, L. Stamm, F. Khan, 2019, HLA.

Identification of a novel HLA‐C allele, HLA‐C*07:778, in an unrelated hematopoietic stem cell donor

N. Berka, L. Stamm, A. Gareau, 2019, HLA.

Characterization of a novel allele, HLA‐C*02:135N, by full‐length gene sequencing in a bone marrow donor

N. Berka, L. Stamm, F. Khan, 2018, HLA.

A novel HLA‐A*26 allele, HLA‐A*26:01:44, identified in a Caucasian individual

N. Berka, L. Stamm, F. Khan, 2018, HLA.

The novel HLA‐B*08:183 allele identified by sequence‐based typing in a Caucasian leukemia patient

N. Berka, L. Stamm, F. Khan, 2017, HLA.

HLA‐DQB1*05:144, a novel allele, discovered in a Southeast Asian donor for stem cell transplantation

N. Berka, L. Stamm, F. Khan, 2017, HLA.

A pathogenic deletion in Forkhead Box L1 (FOXL1) identifies the first otosclerosis (OTSC) gene

P. Hu, S. Agrawal, T. Young, 2021, Human genetics.

Novel approach for UPLC-ESI-Tandem mass spectrometric method for simultaneous determination of olmesartan medoxomil and hydrochlorothiazide in their pharmaceutical combination with kinetic studies of forced degradation

A. Mostafa, Maha Mahmoud Abou-El Alamin, M. Alamin, 2016 .

Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS

A. Mostafa, 2016 .

Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes

E. Randell, Yingchun Han, S. Vasdev, 2007, Molecular and Cellular Biochemistry.

Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma

K. Lawson, D. Morris, J. Spurrell, 2016, Clinical Cancer Research.

The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province

Pramath Kakodkar, J. Shavadia, P. Dokouhaki, 2023, Human Immunology.

Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells

K. Hirasawa, D. Codner, V. Steimle, 2014, PloS one.

Activation of ERa Signaling Differentially Modulates IFN- c Induced HLA-Class II Expression in Breast Cancer Cells

K. Hirasawa, D. Codner, V. Steimle, 2014 .

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer

C. Thirukkumaran, D. Morris, J. Spurrell, 2018, Cancers.

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.

P. L. Bergsagel, G. Nuovo, M. Coffey, 2019, Blood advances.

Comparison of sequence‐specific oligonucleotide probe vs next generation sequencing for HLA‐A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single‐pass high‐resolution HLA typing in support of solid organ and hematopoietic cell transplant programs

A. Jaramillo, Anajane G. Smith, D. Geraghty, 2019, HLA.